SENEB:NASDAQSeneca Foods Corp. Analysis
Data as of 2026-06-17 - not real-time
$160.99
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Seneca Foods (SENEB) is trading at $160.99, well below its DCF‑derived fair value of $283.67, implying a substantial discount. The stock sits above its 20‑day ($147.42) and 50‑day ($144.73) moving averages, with a bullish MACD histogram (+1.92) and a high RSI (71.6), indicating strong upward momentum. Volume is increasing, and the price comfortably clears the identified support at $139.38, while still below the 52‑week high of $178, leaving upside potential.
Fundamentally, the company posted 13.9% revenue growth, a gross margin of 13.9% and an operating margin of 6.4%, while maintaining a low PE of 9.7 and a price‑to‑book of 1.44, suggesting value appeal. Cash generation is solid (operating cash flow $224.5M, free cash flow $92.0M) but debt levels are modest relative to equity (debt‑to‑equity 39.3%). However, volatility is elevated at 46% and average daily volumes are thin, signaling liquidity risk despite a near‑zero beta.
Fundamentally, the company posted 13.9% revenue growth, a gross margin of 13.9% and an operating margin of 6.4%, while maintaining a low PE of 9.7 and a price‑to‑book of 1.44, suggesting value appeal. Cash generation is solid (operating cash flow $224.5M, free cash flow $92.0M) but debt levels are modest relative to equity (debt‑to‑equity 39.3%). However, volatility is elevated at 46% and average daily volumes are thin, signaling liquidity risk despite a near‑zero beta.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical indicators (RSI, MACD, price above SMAs)
- Price trading near support with limited upside to resistance
- High short‑term volatility and thin trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount to DCF fair value
- Solid revenue growth and improving cash flow
- Stable consumer‑defensive sector demand
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervalued fundamentals combined with low beta indicating limited market‑wide risk
- Sustainable earnings power reflected in ROE (16.5%) and ROA (8.0%)
- Long‑run upside as the market re‑prices the company toward its intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth13.90%
Profit Margin6.91%
P/E Ratio9.7
ROE16.51%
ROA8.05%
Debt/Equity39.27
P/B Ratio1.4
Op. Cash Flow$224.5M
Free Cash Flow$92.0M
Technical Analysis
TrendBullish
RSI71.6
Support$139.38
Resistance$178.00
MA 20$147.42
MA 50$144.73
MA 200$125.74
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13
Valuation
Fair Value$283.67
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.02
Volatility46.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.